Preclinical study suggests new approach to reduce COVID-19 death among the elderly

New research reveals a possible new approach to preventing death and severe disease in elderly people infected with SARS-CoV-2. Researchers demonstrated in a preclinical study that senolytic drugs significantly reduced mortality upon infection from a beta-coronavirus closely related to SARS-CoV-2 in older mice.